Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

CRMDCRMD
Showing 8 of 28 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in CORMEDIX INC

Yes. Bank of New York Mellon holds 395,907 shares of CRMD (Cormedix), worth $3.1M, as of its Q2 2026 13F filing. It increased the position by 29,394 shares (+8.0%) from Q1 2026. Bank of New York Mellon has held CRMD in every 13F on record since Q3 2019, 28 quarterly filings.

Current Value

$3.1M

Current Shares

395,907

Total Value Change

+$2.1M

Total Shares Change

+275,994

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
395,907
+8.0%
$3.1M0.0%$7.85
29
2026-Q1
Decreased
366,513
-2.8%
$2.5M0.0%$6.79
0
2025-Q4
Increased
376,907
+45.6%
$4.4M0.0%$11.63
36
2025-Q3
Increased
258,785
+22.7%
$3M0.0%$11.63
32
2025-Q2
Increased
210,940
+47.3%
$2.6M0.0%$12.32
36
2025-Q1
Increased
143,238
+10.4%
$882,3470.0%$6.16
27
2024-Q4
Increased
129,695
+8.2%
$1.1M0.0%$8.10
27
2024-Q3
Decreased
119,913
-24.5%
$968,8960.0%$8.08
0

Other major holders of CRMD: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used